Skip to content

Zymeworks ZYME Lease Liability Payments - Due Year Three

Lease Liability Payments - Due Year Three at other companies

Nurix Therapeutics, Inc. logo
Nurix Therapeutics, Inc.NRIX
$13.46M
BioCryst Pharmaceuticals logo
BioCryst PharmaceuticalsBCRX
$1.54M+9.8%
iRhythm Holdings, Inc.
 logo
iRhythm Holdings, Inc. IRTC
$17.12M+0.6%

Other financials

Income statement

See full
Revenue$2.4M-91.1%
Operating income-$47.1M-84.0%
Net income-$44.2M-95.1%
EPS (diluted)-$0.59-96.7%

Balance sheet

See full
Cash & equivalents$244.3M+221%
Total debt$17.0M-7.7%
Total equity$163.6M-49.7%
Total assets$478.2M+12.4%

Cash flow

See full
Operating cash flow-$45.7M-1,242%
CapEx$216.0K+1,250%
Free cash flow-$45.9M-1,242%

Valuation

See full
Market cap$1.76B+125%
Enterprise value$1.53B+112%
P/S21.6×+13.2×

Profitability

See full
Operating margin-140.4%+7.3pp
Net margin-126.3%+5.0pp
FCF margin-94.8%+15.5pp

Returns & leverage

See full
Return on equity-42%+29.2pp
Debt / equity0.1×0.0×
Current ratio10.8×+6.1×

Where this comes from

Reported directly by Zymeworks in its filing.

Tagged under the XBRL concept us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueInRollingYearThree.

The official record: Zymeworks’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about Zymeworks's lease liability payments - due year three.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Zymeworks's lease liability payments - due year three?
Zymeworks (ZYME) reported lease liability payments - due year three of $3.61M in Q1 2026.
How has Zymeworks's lease liability payments - due year three changed year-over-year?
Zymeworks's lease liability payments - due year three increased by 12.8% year-over-year, from $3.2M to $3.61M.
What does lease liability payments - due year three mean?
The contractual cash obligations for operating and finance leases due in the third year following the balance sheet date. This metric helps in mapping out the long-term fixed cost profile of the company. It is essential for evaluating the sustainability of lease-related cash outflows over a multi-year horizon.